Potential Breakthroughs in the Making
Focused on Innovation to improve cardiovascular health
Through its research and development efforts, Amarin is focused on improving cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science, and the potential therapeutic benefits of polyunsaturated fatty acids including a commitment to future product developments.
Medical Inquiries Form
For medical questions, updated publications, information about our products or any other medical information, please submit your details here and a member of our Medical Affairs team will respond to you.
CV HEALTH
Putting cardiovascular health at the forefront of disease management
Investor Relations
A BOLD investment in cardiometabolic health
Keeping our investors informed about our progress in helping stop cardiovascular disease from being a leading cause of death is important to us. Click here for our investor presentations, events and financial results.
About Amarin
A new paradigm in cardiovascular health management
Amarin Corporation is focused on a BOLD vision to stop cardiovascular disease from being a leading cause of death. Find out more about our vision and how we lead the way to better care for those with cardiovascular disease.
Working at Amarin
A BOLD place for entrepreneurial careers
Are you interested in joining Amarin and being part of our BOLD vision to stop cardiovascular disease from being a leading cause of death worldwide? Click here for more information about our culture, career opportunities, benefits and more.
ALL-NP-00022 1/23
©2025 Amarin Pharmaceuticals Ireland Limited. All rights reserved.
AMARIN, VASCEPA, VAZKEPA and REDUCE-IT names and logos are trademarks of Amarin Pharmaceuticals Ireland Limited. | ALL-NP-00014 1/23
Get In Touch
Whether you’re a patient, a healthcare professional or a job seeker, you can find the best way to contact us from the options below. We’d love to hear from you:
Follow Us
Follow Amarin on our social channels for the latest company news, product campaigns and industry updates:
